Aerovate Therapeutics, Inc. (AVTE): Price and Financial Metrics
AVTE Price/Volume Stats
| Current price | $2.66 | 52-week high | $32.42 |
| Prev. close | $2.67 | 52-week low | $1.25 |
| Day low | $2.63 | Volume | 387,800 |
| Day high | $2.71 | Avg. volume | 614,725 |
| 50-day MA | $2.25 | Dividend yield | N/A |
| 200-day MA | $11.20 | Market Cap | 76.81M |
AVTE Stock Price Chart Interactive Chart >
Aerovate Therapeutics, Inc. (AVTE) Company Bio
Aerovate Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs that enhance the lives of patients with rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.
AVTE Price Returns
| 1-mo | 22.58% |
| 3-mo | 42.25% |
| 6-mo | -84.44% |
| 1-year | -82.59% |
| 3-year | -81.05% |
| 5-year | N/A |
| YTD | -88.25% |
| 2023 | -22.76% |
| 2022 | 148.52% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...